AME Company for Medical Supplies posted a net profit rise of 20% to SAR 26.6 million in H1 2024 from SAR 22.2 million in H1 2023.
| Item | 6m 2023 | 6m 2024 | Change |
|---|---|---|---|
| Revenues | 120.34 | 133.82 | 11.2 % |
| Net Income | 22.20 | 26.59 | 19.8 % |
| Average Shares | 7.00 | 7.00 | - |
| EPS (Riyals) | 3.17 | 3.80 | 19.8 % |
The profit growth was attributed to higher sales of medical supplies and devices by SAR 13.48 million.
This increase resulted from the company's acquisition of a larger market share, which reflected growth in sales driven by increased market demand and effective sales strategies by acquiring new customers and introducing new products to the same existing customers.
The company advertised and marketed products. It also appointed new employees in the sales and marketing departments for greater coverage and faster response to customers.
Shareholders’ equity, with no minority interest, reached SAR 139.7 million as of June 30, 2024, up from SAR 115.5 million a year earlier.
|
Historical Data |
|||
|
Period |
Revenue (SAR mln) |
Net Profit (SAR mln) |
EPS (SAR) |
|
H1 2020 |
44.66 |
4.18 |
0.60 |
|
H2 2020 |
76.94 |
16.89 |
2.41 |
|
H1 2021 |
69.78 |
7.50 |
1.07 |
|
H2 2021 |
81.61 |
13.72 |
1.96 |
|
H1 2022 |
108.35 |
15.38 |
2.20 |
|
H2 2022 |
84.82 |
11.30 |
1.61 |
|
H1 2023 |
120.34 |
22.20 |
3.17 |
|
H2 2023 |
102.98 |
11.32 |
1.62 |
|
H1 2024 |
133.82 |
26.59 |
3.80 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}